The Efficacy of 3% Kanuka Oil Versus 1% Hydrocortisone Cream in Patients With Atopic Dermatitis

Last updated: June 28, 2024
Sponsor: Nexgen Dermatologics, Inc.
Overall Status: Active - Recruiting

Phase

N/A

Condition

Dermatitis, Atopic

Scalp Disorders

Rash

Treatment

3% kanuka oil

Clinical Study ID

NCT06488742
KO-104
  • Ages 12-75
  • All Genders
  • Accepts Healthy Volunteers

Study Summary

Atopic dermatitis is a common disease affecting millions worldwide. A common associated symptom in this population is pruritus. We seek to investigate the use of an natural, over-the-counter cosmeceutical to help this population

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • age greater than 12 years, diagnosis of atopic dermatitis for longer than 2 years,investigator's static global assessment score of either 2 or 3, and initial worstitch numerical rating scale (WI-NRS) for itch greater than 4.

Exclusion

Exclusion Criteria:

  • the use of topical or systemic corticosteroids within 28 days of entering the study,the use of any other non-emollient therapy within 28 days of entering thestudy,nursing, and pregnancy

Study Design

Total Participants: 60
Treatment Group(s): 1
Primary Treatment: 3% kanuka oil
Phase:
Study Start date:
November 01, 2023
Estimated Completion Date:
March 20, 2025

Study Description

There are many treatment options available for atopic dermatitis yet many patients still suffer from the underlying symptomatology. It is important to explore other treatment alternatives to help this population.

Connect with a study center

  • Berlin Center

    Boynton Beach, Florida 33437
    United States

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.